The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: A comprehensive analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: A comprehensive analysis

Published:2018-07-21 Issue:12 Volume:39 Page:1497-1505
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Huang Peng¹²,Liu Mei¹,Zang Feng¹,Yao Yinan¹,Yue Ming³,Wang Jie⁴,Fan Haozhi¹,Zhuo Lingyun¹,Wu Jingjing¹,Xia Xueshan⁵,Feng Yue⁵,Yu Rongbin¹²

Affiliation:

1. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China

2. Key Laboratory of Infectious Diseases, School of Public Health, Nanjing Medical University, Nanjing, China

3. Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

4. Department of Basic and Community Nursing, School of Nursing, Nanjing Medical University, Nanjing, China

5. Faculty of Life Science and Technology, Kunming University of Science and Technology, Chenggong District, Kunming, Yunnan, China

Funder

National Natural Science Foundation of China

Science and Technology Development Fund

Natural Science Foundation of Jiangsu Province

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/39/12/1497/27366040/bgy099.pdf

Reference47 articles.

1. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go;El-Serag;Hepatology,2014

2. Lessons from epidemiology: the burden of liver disease;Rowe;Dig. Dis,2017

3. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;Sulkowski;N. Engl. J. Med,2014

4. HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: the ITAL-C network study;Ippolito;Dig. Liver Dis,2017

5. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis;Nishiguchi;Lancet,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese herbal medicine decreases incidence of hepatocellular carcinoma in diabetes mellitus patients with regular insulin management;World Journal of Gastrointestinal Oncology;2024-03-15

2. Trends in long‐term outcomes of patients with HCV‐associated hepatocellular carcinoma after hepatectomy: A comparison before and after introduction of direct‐acting antivirus therapy;Annals of Gastroenterological Surgery;2023-08-07

3. Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications;Cancers;2023-06-30

4. Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma;Molecular Oncology;2023-01-21

5. Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal;Hepatoma Research;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3